94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Oncol. , 13 September 2023
Sec. Neuro-Oncology and Neurosurgical Oncology
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1278074
This article is part of the Research Topic Tumor Accommodation: The Importance of the Niche in Neurological Tumors View all 5 articles
This article is a correction to:
Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: A case report and review of the literature
by Lolli J, Tessari F, Berti F, Fusella M, Fiorentin D, Bimbatti D, Basso U and Busato F (2023) Front. Oncol. 13:1136300. doi: 10.3389/fonc.2023.1136300
In the published article, there was an error in the Funding statement as it was not specified that this research was funded by the Italian Ministry of Health Ricerca Corrente. The correct Funding statement appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
This research was funded by Italian Ministry of Health Ricerca Corrente.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: cabozantinib, radionecrosis (RN), stereotacic radiation, immunotherapy, radiosurgery
Citation: Lolli J, Tessari F, Berti F, Fusella M, Fiorentin D, Bimbatti D, Basso U and Busato F (2023) Corrigendum: Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: a case report and review of the literature. Front. Oncol. 13:1278074. doi: 10.3389/fonc.2023.1278074
Received: 15 August 2023; Accepted: 29 August 2023;
Published: 13 September 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Lolli, Tessari, Berti, Fusella, Fiorentin, Bimbatti, Basso and Busato. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Fabio Busato, ZmFiaW8xOTg4YnVzYXRvQGdtYWlsLmNvbQ==
†These authors have contributed equally to this work
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.